Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated “Real-World” in Patients With Atrial Fibrillation-Reference-Cited by-同舟云学术

Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated “Real-World” in Patients With Atrial Fibrillation

Published:2018-09 Issue:5 Volume:122 Page:785-792
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Esteve-Pastor María Asunción^ORCID,Rivera-Caravaca José Miguel^ORCID,Roldán Vanessa,Orenes-Piñero Esteban,Romiti Giulio Francesco,Romanazzi Imma,Bai Ying^ORCID,Carmo João,Proietti Marco^ORCID,Marín Francisco^ORCID,Lip Gregory Y.H.

Funder

ISCIII

FEDER

Fundación Séneca

Instituto Murciano de Investigación Biosanitaria and Sociedad Española de Trombosis y Hemostasia

Sociedad Española de Trombosis y Hemostasia

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation;Hart;Ann Intern Med,2007